- Professor of Diabetic Medicine (Institute of Cardiovascular and Medical Sciences)
John Petrie is Professor of Diabetic Medicine at the University of Glasgow. He is an Honorary Consultant Physician and Diabetologist at Glasgow Royal Infirmary and Stobhill Hospital, Glasgow.
Professor Petrie’s research aims better to understand the mechanisms of vascular disease associated with insulin resistance in diabetes and thereby to improve their health. His work includes intensive phenotyping studies (e.g. euglycaemic clamp), larger scale cohort studies (e.g. RISC of which he is on the Project Management Board), and biomarker discovery/validation.
In December 2010 he was awarded a major 5-year research award by the US Juvenile Diabetes Research Foundation for the REMOVAL trial (of which he is Chief Investigator). REMOVAL is an international double-blind randomized placebo-controlled clinical trial testing the cardiovascular effects of metformin on the complications of type 1 diabetes recruiting participants in the UK, Denmark, Holland, Canada, and Australia. It involves collaborations with Imperial College London (UK), the University of Wisconsin- Madison (USA), the Steno Diabetes Center (Denmark), the NHMRC Clinical Trials Centre in Sydney (Australia) and the Robarts Research Institute in Ontario(Canada) - as well as with commercial partner organizations. Trial Coordination is via the Robertson Centre for Biostatistics (University of Glasgow) within the Glasgow Clinical Trials Unit.
Professor Petrie’s research has been supported by bodies including the Chief Scientist Office, British Heart Foundation, Diabetes UK and the Juvenile Diabetes Research Foundation.
Professor Petrie’s clinical PhD was in Glasgow and was followed by postdoctoral training there as a Clinical Lecturer. From 2006, he led the initiation and development of the Scottish Diabetes Research Network (SDRN) from the University of Dundee. He remains active on the SDRN Steering Group.
He has served on and/or chaired a number of grant-awarding panels/ advisory committees including for: the US Juvenile Diabetes Research Foundation, the European Foundation for the Study of Diabetes, the UK National Institute for Healthcare Research, Diabetes UK, the Chief Scientist Office, and the NovoNordisk UK Research Foundation.
Professor Petrie was a founding member of the International Society of Diabetes and Vascular Disease Research (2004) and is President of the European Group for the study of Insulin Resistance (2010). In 2009-10 he chaired the development of the Scottish Intercollegiate Guidelines Network (SIGN) guidance on glucose-lowering in type 2 diabetes. He is an Associate Editor of the journal of the European Association for the Study of Diabetes journal Diabetologia.